Filtered By:
Source: Asian Pacific Journal of Cancer Prevention
This page shows you your search results in order of date. This is page number 5.
Order by Relevance | Date
Total 1106 results found since Jan 2013.
The Prevalence of MYD88 L265P and TNFAIP3 Mutations and Their Correlations with Clinico-Hematological Profile in Egyptian Patients with Diffuse Large B Cell Lymphoma
CONCLUSION: MYD88 L265P and to lesser extent TNFAIP3 mutations are major mutations in ABC- DLBCL and may be predictive factors for poor OS in ABC- DLBCL patients.PMID:37505783 | DOI:10.31557/APJCP.2023.24.7.2485
Source: Asian Pacific Journal of Cancer Prevention - July 28, 2023 Category: Cancer & Oncology Authors: Osama Elbaz Rana M Shaat Hasan A Abd El Ghaffar Sameh Shamaa Hanaa M Abdel-Masseih Nahla Anber Metwaly Ibrahim Mortada Source Type: research
Complete Decongestive Therapy Effect on Breast Cancer Related to Lymphedema: A Systemic Review and Meta-Analysis of Randomized Controlled Trials
CONCLUSIONS: The CDT is still recommended as the primary therapy for BCRL and is regarded the most practical and cost-effective treatment for BCRL. This result recommends patients to perform CDT to improve their QOL, ROM, and to lessen pain and edema volume. To improve the body of evidence supporting the effectiveness of the CDT on BCRL, additional trials with bigger sample sizes, longer follow-ups, blindness outcomes, and patient compliance evaluations are required.PMID:37505751 | DOI:10.31557/APJCP.2023.24.7.2225
Source: Asian Pacific Journal of Cancer Prevention - July 28, 2023 Category: Cancer & Oncology Authors: Shaimaa Shamoun Muayyad Ahmad Source Type: research
What is the Role of SNORA42 in Carcinogenesis? A Systematic Review
CONCLUSION: The summary of the main information about SNORA42 in the process of carcinogenesis and cancer progression shows that the use of this snoRNA is ideal for future applications in the field of oncology, in which it can be used as a biomarker and therapeutic target. Thus, it is of fundamental importance to carry out new studies to consolidate the applicability of this molecule.PMID:37505750 | DOI:10.31557/APJCP.2023.24.7.2217
Source: Asian Pacific Journal of Cancer Prevention - July 28, 2023 Category: Cancer & Oncology Authors: Eldevan Da Silva Barbosa Ana Gabrielly De Melo Matos Marcelli Geisse De Oliveira Prata Da Silva Matheus Silva Alves Antonio Augusto Lima Teixeira-J únior Wesliany Everton Duarte Alania Frank Mendon ça Carolina Rosal Teixeira De Souza Marcelo Souza De An Source Type: research
Complete Decongestive Therapy Effect on Breast Cancer Related to Lymphedema: A Systemic Review and Meta-Analysis of Randomized Controlled Trials
CONCLUSIONS: The CDT is still recommended as the primary therapy for BCRL and is regarded the most practical and cost-effective treatment for BCRL. This result recommends patients to perform CDT to improve their QOL, ROM, and to lessen pain and edema volume. To improve the body of evidence supporting the effectiveness of the CDT on BCRL, additional trials with bigger sample sizes, longer follow-ups, blindness outcomes, and patient compliance evaluations are required.PMID:37505751 | DOI:10.31557/APJCP.2023.24.7.2225
Source: Asian Pacific Journal of Cancer Prevention - July 28, 2023 Category: Cancer & Oncology Authors: Shaimaa Shamoun Muayyad Ahmad Source Type: research
What is the Role of SNORA42 in Carcinogenesis? A Systematic Review
CONCLUSION: The summary of the main information about SNORA42 in the process of carcinogenesis and cancer progression shows that the use of this snoRNA is ideal for future applications in the field of oncology, in which it can be used as a biomarker and therapeutic target. Thus, it is of fundamental importance to carry out new studies to consolidate the applicability of this molecule.PMID:37505750 | DOI:10.31557/APJCP.2023.24.7.2217
Source: Asian Pacific Journal of Cancer Prevention - July 28, 2023 Category: Cancer & Oncology Authors: Eldevan Da Silva Barbosa Ana Gabrielly De Melo Matos Marcelli Geisse De Oliveira Prata Da Silva Matheus Silva Alves Antonio Augusto Lima Teixeira-J únior Wesliany Everton Duarte Alania Frank Mendon ça Carolina Rosal Teixeira De Souza Marcelo Souza De An Source Type: research
Complete Decongestive Therapy Effect on Breast Cancer Related to Lymphedema: A Systemic Review and Meta-Analysis of Randomized Controlled Trials
CONCLUSIONS: The CDT is still recommended as the primary therapy for BCRL and is regarded the most practical and cost-effective treatment for BCRL. This result recommends patients to perform CDT to improve their QOL, ROM, and to lessen pain and edema volume. To improve the body of evidence supporting the effectiveness of the CDT on BCRL, additional trials with bigger sample sizes, longer follow-ups, blindness outcomes, and patient compliance evaluations are required.PMID:37505751 | DOI:10.31557/APJCP.2023.24.7.2225
Source: Asian Pacific Journal of Cancer Prevention - July 28, 2023 Category: Cancer & Oncology Authors: Shaimaa Shamoun Muayyad Ahmad Source Type: research
What is the Role of SNORA42 in Carcinogenesis? A Systematic Review
CONCLUSION: The summary of the main information about SNORA42 in the process of carcinogenesis and cancer progression shows that the use of this snoRNA is ideal for future applications in the field of oncology, in which it can be used as a biomarker and therapeutic target. Thus, it is of fundamental importance to carry out new studies to consolidate the applicability of this molecule.PMID:37505750 | DOI:10.31557/APJCP.2023.24.7.2217
Source: Asian Pacific Journal of Cancer Prevention - July 28, 2023 Category: Cancer & Oncology Authors: Eldevan Da Silva Barbosa Ana Gabrielly De Melo Matos Marcelli Geisse De Oliveira Prata Da Silva Matheus Silva Alves Antonio Augusto Lima Teixeira-J únior Wesliany Everton Duarte Alania Frank Mendon ça Carolina Rosal Teixeira De Souza Marcelo Souza De An Source Type: research
The Prevalence of MYD88 L265P and TNFAIP3 Mutations and Their Correlations with Clinico-Hematological Profile in Egyptian Patients with Diffuse Large B Cell Lymphoma
CONCLUSION: MYD88 L265P and to lesser extent TNFAIP3 mutations are major mutations in ABC- DLBCL and may be predictive factors for poor OS in ABC- DLBCL patients.PMID:37505783 | DOI:10.31557/APJCP.2023.24.7.2485
Source: Asian Pacific Journal of Cancer Prevention - July 28, 2023 Category: Cancer & Oncology Authors: Osama Elbaz Rana M Shaat Hasan A Abd El Ghaffar Sameh Shamaa Hanaa M Abdel-Masseih Nahla Anber Metwaly Ibrahim Mortada Source Type: research
Complete Decongestive Therapy Effect on Breast Cancer Related to Lymphedema: A Systemic Review and Meta-Analysis of Randomized Controlled Trials
CONCLUSIONS: The CDT is still recommended as the primary therapy for BCRL and is regarded the most practical and cost-effective treatment for BCRL. This result recommends patients to perform CDT to improve their QOL, ROM, and to lessen pain and edema volume. To improve the body of evidence supporting the effectiveness of the CDT on BCRL, additional trials with bigger sample sizes, longer follow-ups, blindness outcomes, and patient compliance evaluations are required.PMID:37505751 | DOI:10.31557/APJCP.2023.24.7.2225
Source: Asian Pacific Journal of Cancer Prevention - July 28, 2023 Category: Cancer & Oncology Authors: Shaimaa Shamoun Muayyad Ahmad Source Type: research
The Prevalence of MYD88 L265P and TNFAIP3 Mutations and Their Correlations with Clinico-Hematological Profile in Egyptian Patients with Diffuse Large B Cell Lymphoma
CONCLUSION: MYD88 L265P and to lesser extent TNFAIP3 mutations are major mutations in ABC- DLBCL and may be predictive factors for poor OS in ABC- DLBCL patients.PMID:37505783 | DOI:10.31557/APJCP.2023.24.7.2485
Source: Asian Pacific Journal of Cancer Prevention - July 28, 2023 Category: Cancer & Oncology Authors: Osama Elbaz Rana M Shaat Hasan A Abd El Ghaffar Sameh Shamaa Hanaa M Abdel-Masseih Nahla Anber Metwaly Ibrahim Mortada Source Type: research
What is the Role of SNORA42 in Carcinogenesis? A Systematic Review
CONCLUSION: The summary of the main information about SNORA42 in the process of carcinogenesis and cancer progression shows that the use of this snoRNA is ideal for future applications in the field of oncology, in which it can be used as a biomarker and therapeutic target. Thus, it is of fundamental importance to carry out new studies to consolidate the applicability of this molecule.PMID:37505750 | DOI:10.31557/APJCP.2023.24.7.2217
Source: Asian Pacific Journal of Cancer Prevention - July 28, 2023 Category: Cancer & Oncology Authors: Eldevan Da Silva Barbosa Ana Gabrielly De Melo Matos Marcelli Geisse De Oliveira Prata Da Silva Matheus Silva Alves Antonio Augusto Lima Teixeira-J únior Wesliany Everton Duarte Alania Frank Mendon ça Carolina Rosal Teixeira De Souza Marcelo Souza De An Source Type: research
Complete Decongestive Therapy Effect on Breast Cancer Related to Lymphedema: A Systemic Review and Meta-Analysis of Randomized Controlled Trials
CONCLUSIONS: The CDT is still recommended as the primary therapy for BCRL and is regarded the most practical and cost-effective treatment for BCRL. This result recommends patients to perform CDT to improve their QOL, ROM, and to lessen pain and edema volume. To improve the body of evidence supporting the effectiveness of the CDT on BCRL, additional trials with bigger sample sizes, longer follow-ups, blindness outcomes, and patient compliance evaluations are required.PMID:37505751 | DOI:10.31557/APJCP.2023.24.7.2225
Source: Asian Pacific Journal of Cancer Prevention - July 28, 2023 Category: Cancer & Oncology Authors: Shaimaa Shamoun Muayyad Ahmad Source Type: research
What is the Role of SNORA42 in Carcinogenesis? A Systematic Review
CONCLUSION: The summary of the main information about SNORA42 in the process of carcinogenesis and cancer progression shows that the use of this snoRNA is ideal for future applications in the field of oncology, in which it can be used as a biomarker and therapeutic target. Thus, it is of fundamental importance to carry out new studies to consolidate the applicability of this molecule.PMID:37505750 | DOI:10.31557/APJCP.2023.24.7.2217
Source: Asian Pacific Journal of Cancer Prevention - July 28, 2023 Category: Cancer & Oncology Authors: Eldevan Da Silva Barbosa Ana Gabrielly De Melo Matos Marcelli Geisse De Oliveira Prata Da Silva Matheus Silva Alves Antonio Augusto Lima Teixeira-J únior Wesliany Everton Duarte Alania Frank Mendon ça Carolina Rosal Teixeira De Souza Marcelo Souza De An Source Type: research
The Prevalence of MYD88 L265P and TNFAIP3 Mutations and Their Correlations with Clinico-Hematological Profile in Egyptian Patients with Diffuse Large B Cell Lymphoma
CONCLUSION: MYD88 L265P and to lesser extent TNFAIP3 mutations are major mutations in ABC- DLBCL and may be predictive factors for poor OS in ABC- DLBCL patients.PMID:37505783 | DOI:10.31557/APJCP.2023.24.7.2485
Source: Asian Pacific Journal of Cancer Prevention - July 28, 2023 Category: Cancer & Oncology Authors: Osama Elbaz Rana M Shaat Hasan A Abd El Ghaffar Sameh Shamaa Hanaa M Abdel-Masseih Nahla Anber Metwaly Ibrahim Mortada Source Type: research
